Are bioequivalence (BE) assessments of clinical significance and relevance? Not really!

A discussion is provided showing the weakness of BE assessments for comparing or establishing the quality of products such as tablets/capsules. It is argued that in vitro drug dissolution/release testing would provide a better alternative for the assessment of the quality of such pharmaceutical products. Please click here for complete article.

Related Posts